What ROGAINE does

ROGAINE is a US-based consumer health brand focused on over-the-counter topical hair regrowth treatments. Founded in 1988, it markets the first FDA-approved topical treatment for androgenic alopecia, using minoxidil as the active pharmaceutical ingredient at 5% concentration for men and 2% (with a 5% foam option) for women, alongside proprietary Tricho-Prime Technology. The product line spans minoxidil foams and solutions for men and women, with a recently expanded haircare range of thickening, pre-growth, and anti-dandruff shampoo + conditioner variants that are positioned as a regimen alongside the core minoxidil treatment.

The business operates a product-led growth model with multi-channel distribution: direct-to-consumer e-commerce on rogaine.com, Amazon Marketplace (with a Subscribe & Save subscription option offering up to 15% off), and broad retail availability across US pharmacies and mass merchants. Pricing is published only indirectly via retailer channels; the brand offers a money-back guarantee with refunds up to $94.00 after 120 days of daily use. Customer segmentation is horizontal across men and women with hereditary pattern hair loss, with content marketing (blog, quiz, testimonials) and a strong dermatologist-oriented channel (including AAD conference presence) supporting acquisition and retention.

The brand is wholly owned by Kenvue Inc. (NYSE: KVUE), the consumer health company spun off from Johnson & Johnson in November 2023, and operated under Kenvue Brands LLC headquartered in Summit, New Jersey. Rogaine's commercial posture emphasizes more than 35 years of clinical evidence, including trials covering over 47,000 participants, positioning it as the #1 dermatologist recommended hair regrowth brand. The legal entity size reported is 1-10 employees, indicating that strategic, financial, and operational scale is delivered through the Kenvue parent rather than a standalone organization.

Name

ROGAINE

Legal name

Kenvue Brands LLC

Website

https://rogaine.com

Company type

Private

Founded year

1988

Operating status

Operating

Headcount range

1–10 employees

Short description

ROGAINE is an OTC topical hair regrowth brand selling FDA-approved minoxidil foam and solution products for men and women, distributed via rogaine.com, Amazon, and US pharmacies, and wholly owned by Kenvue Inc.

Ownership category

akta.pro rank

Product category

OTC Hair Regrowth Treatments

NAICS

Soap and Cleaning Compound Manufacturing (32561), Cosmetics, Beauty Supplies, and Perfume Retailers (456120)

SIC

Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics (2840), Perfumes, Cosmetics & Other Toilet Preparations (2844)

akta.pro primary industry

Treatments & Scalp Care (Serums, Oils, Anti-dandruff, Growth) (CRABABAE)

akta.pro secondary industries

Shampoo & Scalp Cleansers (CRABABAA), Conditioners & Hair Masks (CRABABAB)

Keywords

• Hair regrowth treatment
• Minoxidil products
• OTC hair loss
• Topical dermatology
• Hair care products

Headquarters

HQ city

Skillman

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Marketing or Sales, Supply Chain, Operations, Technology or R&D, Personnel

Revenue model

1. Direct Product Sales (DTC): Rogaine sells products directly to consumers through its website rogaine.com, offering both one-time purchases and subscription options. Products include minoxidil foam and solution in various sizes for men and women.
2. Retail Distribution: Products sold through major retail chains including pharmacies and mass merchants. Wide availability in most retailers across the United States.
3. Amazon Marketplace (Subscribe & Save): Products available on Amazon with subscription options offering up to 15% savings. Recurring revenue through auto-delivery subscriptions.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

ROGAINE sells FDA-approved topical minoxidil-based hair regrowth treatments in foam and solution formats at 5% concentration for men and at 2% and 5% concentrations for women, available over the counter without a prescription. The brand also offers supporting shampoo and conditioner products (Thickening, Pre-Growth, and Anti-Dandruff) designed for use alongside the minoxidil regimen. Products are sold direct-to-consumer via rogaine.com, through Amazon (including Subscribe & Save), and across retail pharmacies and mass merchants in the United States.

Product overview

ROGAINE is a portfolio of FDA-approved topical hair regrowth treatments containing minoxidil as the active ingredient. The core product line consists of minoxidil foam and solution formulations in different concentrations for men (5%) and women (2% and 5%). Supporting the minoxidil treatments is a range of shampoo and conditioner products (Thickening, Pre-Growth, and Anti-Dandruff variants) designed for use alongside the hair regrowth treatments. ROGAINE is the #1 dermatologist recommended brand, part of Kenvue Inc., with over 35 years of clinically proven hair regrowth results tested on over 47,000 people.

Differentiator

Problem solved

Functional benefit

Brands

• Men's ROGAINE: Hair regrowth products specifically formulated and labeled for men, including 5% Minoxidil Foam and Solution products.
• Women's ROGAINE
• ROGAINE Shampoo + Conditioner Products

Products and services

• Men's ROGAINE 5% Minoxidil Unscented Foam FDA-approved topical 5% minoxidil foam for men, applied twice daily to the crown of the scalp to reactivate hair follicles and stimulate regrowth; clinically tested to deliver visible results in 3-4 months. Targeted at men experiencing hereditary hair loss or pattern baldness.
• Men's ROGAINE 5% Minoxidil Solution FDA-approved topical 5% minoxidil liquid solution for men, applied twice daily via included dropper for precision application, suggested for longer hair. Targeted at men with hereditary hair loss seeking precise dose-controlled application.
• Women's ROGAINE 5% Minoxidil Unscented Foam FDA-approved once-daily 5% minoxidil foam for women, easy to apply to larger areas with reduced dripping and no unpleasant odor. Winner of Allure Magazine 2023 Best of Beauty Award. Targeted at women with female pattern hair loss or thinning at the part line and crown.
• Women's ROGAINE 2% Minoxidil Solution FDA-approved 2% minoxidil topical solution for women, applied twice daily with included dropper, clinically proven to regrow hair 61% thicker. Targeted at women with female pattern hair loss seeking a precision application format.
• Men's ROGAINE Hair Thickening 2-in-1 Shampoo + Conditioner Thickening 2-in-1 shampoo and conditioner designed for use alongside men's minoxidil hair regrowth treatments; delivers 2X fuller-looking hair after one wash and helps reduce shedding due to breakage. Targeted at men building a complete regrowth routine.
• Men's ROGAINE Pre-Growth Shampoo + Conditioner Pre-growth 2-in-1 shampoo and conditioner that clears 98% of scalp build-up with a Triple Acid Complex (mandelic, hyaluronic, lactic acids), prepping the scalp so subsequent minoxidil treatments can reach full potential. Targeted at men layering a preparatory step into a regrowth routine.
• Men's ROGAINE 2% Salicylic Acid Anti-Dandruff Shampoo + Conditioner Anti-dandruff 2-in-1 shampoo and conditioner with 2% salicylic acid that fights dandruff, relieves scalp itching and irritation, reduces redness and flaking, and helps minimize breakage-related hair loss. Targeted at men with dandruff-related scalp issues that compound hair thinning.

Quantifiable outcome

• 9 out of 10 men noticed results using Men's ROGAINE foam twice daily for 16 weeks vs. placebo
• +3 more outcomes

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Three partnerships are on record, tiered core and minor.

• Kenvue Inc.coreStrategic or Co-development Partner · 27 March 2026Rogaine is a brand under Kenvue Inc., the world's largest pure-play consumer health company (spun off from Johnson & Johnson in 2023). Kenvue portfolio includes other dermatology brands Neutrogena and Aveeno. Rogaine participates in joint research initiatives and dermatology conferences under the Kenvue umbrella.
• Boards University (Resident's Corner Program)minorStrategic or Co-development Partner · 27 March 2026Partnership with Boards University for the Resident's Corner program supporting dermatology trainee education and professional development, announced at the 2026 American Academy of Dermatology Annual Meeting.
• AmazoncoreChannel Partner/ Reseller/ DistributorAmazon serves as a major distribution channel for Rogaine products through Amazon's marketplace and Subscribe & Save program, offering up to 15% discount on subscriptions.

Scale indicators5 records

Recent moves5 records

Expansion highlights3 records

Direct peers

• Hims & Hers Health: Hims & Hers sells minoxidil, finasteride, and other hair loss treatments online, including a dedicated Hers brand for women. It is a direct competitor to Rogaine in the OTC and prescription hair regrowth space, particularly in DTC and telehealth channels.
• Keeps: Keeps is a direct-to-consumer subscription brand offering FDA-approved minoxidil and finasteride products for male pattern hair loss. It competes head-to-head with Rogaine in the same active-ingredient category via a similar online + telehealth model.
• Bosley: Bosley is a leading hair restoration company offering surgical transplants, PRP, and at-home topicals. It competes with Rogaine for consumers with progressive hair loss considering clinical-grade solutions.
• Nioxin: Nioxin is a long-established thinning-hair brand sold primarily through salons and professional channels, offering scalp and hair thickening systems. It targets the same thinning-hair consumer with complementary, non-minoxidil formulations.
• Nutrafol: Nutrafol sells clinically tested, natural hair growth supplements targeting thinning hair in men and women. It competes for the same hair-loss consumer wallet with a different mechanism (oral nutraceutical vs. topical minoxidil).
• Keranique: Keranique is a women's-focused hair regrowth system featuring minoxidil-based topicals and supporting haircare. It competes directly with Women's Rogaine on formulations, target customer, and retail/DTC channels.
• Viviscal: Viviscal is a hair growth supplement brand clinically studied for thinning hair in men and women. It competes with Rogaine via an oral supplement mechanism targeting the same hair loss consumer.
• DS Laboratories: DS Laboratories sells dermatologist-formulated hair growth treatments including minoxidil-based and novel topical products. It competes in the same OTC/clinical hair regrowth category as Rogaine.

Emerging players

• Happy Head: Happy Head is a dermatologist-prescribed, custom-compounded topical hair growth company. It represents an emerging telehealth-enabled alternative that uses stronger formulations than OTC minoxidil, competing for the same progressive hair loss consumer.
• Vegamour: Vegamour is a plant-based hair growth and scalp care brand sold direct-to-consumer. It targets the same thinning-hair consumer with vegan alternatives, representing an emerging natural-beauty competitor to Rogaine.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/Rogaine
• LinkedInlinkedin.com/company/rogaine

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ROGAINE